Assessment of atrial and ventricular electromechanical delay, as a cardiotoxicity parameter in patients with trastuzumab chemotherapy for her2 positive breast cancer patient.
Event:
ESC Congress 2016
Topic:
Cardiotoxicity of drugs
Session:
Heart failure/LV dysfunction
